Trilaciclib Impurity 14 | CAS 571189-49-6 - Request Quote
Trilaciclib Impurity 14
| SZ CAT No: | SZ-T156020 |
| CAS No | 571189-49-6 |
| Mol.F. | C10H16N4 |
| Mol.Wt. | 192.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Trilaciclib Impurity 14 is chemically 5-(4-Methylpiperazin-1-yl)pyridin-2-amine. Trilaciclib Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Trilaciclib Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Trilaciclib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 571189-49-6
Purchase 571189-49-6
Order 571189-49-6
Enquire 571189-49-6
price of 571189-49-6
571189-49-6 Supplier
571189-49-6 Manufacturer
571189-49-6 Exporter
buy high quality Trilaciclib Impurity 14
Purchase Trilaciclib Impurity 14
Trilaciclib Impurity 14 suppliers
Trilaciclib Impurity 14 manufacturers
Trilaciclib Impurity 14 price
Order Trilaciclib Impurity 14
Enquire Trilaciclib Impurity 14
Trilaciclib Impurity 14 cost
Trilaciclib Impurity 14 Supplier
Trilaciclib Impurity 14 Distributor
Trilaciclib Impurity 14 for Method Validation
Trilaciclib Reference Standard
Trilaciclib Impurity 14 for ANDA Filing
Trilaciclib Impurity 14 for Forced Degradation Studies
Trilaciclib Impurity 14 Identification Standards
Trilaciclib Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


